FundedIQ
Biotechnology

Girihlet: Funding, Investors & Team (Oct 2026)

Girihlet is a provider of rapid and accurate deep sequencing services with a unique focus on developing novel technologies. Girihlet currently specializes in inexpensively sequencing and analyzing mtDNA and T cell receptors using novel, bias-free methods in order to harness their power as biomarkers for diagnostics in a variety of disorders.

www.girihlet.com LinkedIn Brooklyn, United States 1-10 employees
Biotechnology Genetics Health Diagnostics Medical
Total raised
$500k
Rounds
1
Latest
Debt Financing
Mar 2022

Girihlet has raised $500k across 1 funding round on record, the most recent a Debt Financing of $500k announced in Mar 2022.

That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Girihlet Company Profile and Key Stats

Total funding raised
$500k
across 1 round on record
Funding rounds on record
1
Latest funding round
Debt Financing
$500k in Mar 2022
Employees
1-10
reported band
Headquarters
Brooklyn, United States

Latest funding round on record: Mar 2022.

Girihlet Funding Rounds

Date
Round
Amount
Debt Financing
$500k

Girihlet Founders and Leadership Team

Name
Role
Contact
Anitha Jayaprakash
CEO
Locked

Contact details for the Girihlet team: 1 of 1 has an email address on file.

Start 14-day free trial →

Girihlet Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M

Girihlet's latest round of $500k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Girihlet in Biotechnology and Brooklyn

Companies Similar to Girihlet

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Girihlet Funding FAQs

What does Girihlet do?

Girihlet is a provider of rapid and accurate deep sequencing services with a unique focus on developing novel technologies. Girihlet currently specializes in inexpensively sequencing and analyzing mtDNA and T cell receptors using novel, bias-free methods in order to harness their power as biomarkers for diagnostics in a variety of disorders.

How much funding has Girihlet raised?

Girihlet has raised $500k across 1 round on record. The most recent is a Debt Financing of $500k announced in Mar 2022.

When did Girihlet last raise funding?

Girihlet's most recent funding round on record is a Debt Financing of $500k, announced in Mar 2022.

Who is the CEO of Girihlet?

Anitha Jayaprakash is listed as CEO at Girihlet.

Where is Girihlet headquartered?

Girihlet is based in Brooklyn, New York, United States.

How many employees does Girihlet have?

Girihlet is in the 1-10 employee band.

How does Girihlet's funding compare to other Biotechnology startups?

Girihlet's latest round of $500k is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Girihlet Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Girihlet is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.